# First Citizens Bancshares Inc: overview

FCNCA · Nasdaq · CIK 798941 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcnca.md) · [Financials](/companies/fcnca/financials.md) · [Filings](/companies/fcnca/filings.md) · [Insiders](/companies/fcnca/insiders.md)

Latest reported revenue: [$2.43bn](/filings/0000798941-26-000031.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0000798941-26-000031).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,446](/filings/0000798941-25-000050.md) | [2,408 d](/filings/0000798941-26-000015.md) | [2,298](/filings/0000798941-26-000024.md) | [2,373](/filings/0000798941-26-000031.md) | [2,433](/filings/0000798941-25-000050.md) | [2,437 d](/filings/0000798941-26-000015.md) | [2,313](/filings/0000798941-26-000024.md) | [2,432](/filings/0000798941-26-000031.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [26.1%](/filings/0000798941-25-000050.md) | [29.1% d](/filings/0000798941-26-000015.md) | [21.0%](/filings/0000798941-26-000024.md) | [24.2%](/filings/0000798941-26-000031.md) | [23.3%](/filings/0000798941-25-000050.md) | [23.8% d](/filings/0000798941-26-000015.md) | [23.1%](/filings/0000798941-26-000024.md) | [27.6%](/filings/0000798941-26-000031.md) |
| Diluted EPS | $ per share | [43.42](/filings/0000798941-25-000050.md) | not reported | [34.47](/filings/0000798941-26-000024.md) | [42.36](/filings/0000798941-26-000031.md) | [43.08](/filings/0000798941-25-000050.md) | not reported | [42.63](/filings/0000798941-26-000024.md) | [55.52](/filings/0000798941-26-000031.md) |
| Free cash flow | $m | [885 d](/filings/0000798941-25-000050.md) | [991 d](/filings/0000798941-26-000015.md) | [(5.0)](/filings/0000798941-26-000024.md) | [733 d](/filings/0000798941-26-000031.md) | [678 d](/filings/0000798941-25-000050.md) | [807 d](/filings/0000798941-26-000015.md) | [31.0](/filings/0000798941-26-000024.md) | [941 d](/filings/0000798941-26-000031.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | not reported | [5.1](/filings/0000798941-25-000010.md) | [18.8](/filings/0000798941-26-000015.md) | [9.8](/filings/0000798941-26-000015.md) | [9.5](/filings/0000798941-26-000015.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [21.6%](/filings/0000798941-25-000010.md) | [61.0%](/filings/0000798941-26-000015.md) | [28.5%](/filings/0000798941-26-000015.md) | [23.1%](/filings/0000798941-26-000015.md) |
| Diluted EPS | $ per share | [53.88](/filings/0000798941-24-000018.md) | [67.40](/filings/0000798941-25-000010.md) | [784.51](/filings/0000798941-26-000015.md) | [189.41](/filings/0000798941-26-000015.md) | [165.24](/filings/0000798941-26-000015.md) |
| Free cash flow | $bn | [(0.4)](/filings/0000798941-24-000018.md) | [2.6](/filings/0000798941-25-000010.md) | [2.3](/filings/0000798941-26-000015.md) | [2.6](/filings/0000798941-26-000015.md) | [2.2](/filings/0000798941-26-000015.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fcnca/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $1.91bn | 919,347 |  | Reduced −28,754 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.79bn | 859,143 |  | Reduced −145,107 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $841.1m | 404,215 |  | Added +11,128 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $746.1m | 358,575 |  | Reduced −28,839 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $649.9m | 312,316 |  | Reduced −36,407 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $433.3m | 208,230 |  | Reduced −14,810 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $384.3m | 184,805 |  | Reduced −79,809 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $356.7m | 171,811 |  | Reduced −9,161 |
| [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $322.4m | 154,960 |  | Added +22,130 |
| [COATUE MANAGEMENT LLC](/funds/1135730.md) | 2026-06-30 | $290.3m | 139,498 |  | Unchanged |

## Recent filings

[All 1,272 filings](/companies/fcnca/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 06:31 ET | [8-K](/filings/0000798941-26-000041.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000798941-26-000041 |
| 2026-09-14 | 16:10 ET | [8-K](/filings/0001193125-26-390576.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-390576 |
| 2026-09-08 | 08:25 ET | [8-K](/filings/0000798941-26-000034.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000798941-26-000034 |
| 2026-08-11 | 17:10 ET | [SCHEDULE 13D/A](/filings/0001193125-26-344990.md) | Ownership report, active investor, amended | 0001193125-26-344990 |
| 2026-08-07 | 08:33 ET | [10-Q](/filings/0000798941-26-000031.md) | Quarterly report, period 2026-06-30 | 0000798941-26-000031 |
| 2026-07-23 | 06:32 ET | [8-K](/filings/0000798941-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000798941-26-000027 |
| 2026-05-08 | 09:12 ET | [10-Q](/filings/0000798941-26-000024.md) | Quarterly report, period 2026-03-31 | 0000798941-26-000024 |
| 2026-05-07 | 09:18 ET | [8-K](/filings/0000798941-26-000020.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000798941-26-000020 |
| 2026-04-23 | 06:55 ET | [8-K](/filings/0000798941-26-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000798941-26-000018 |
| 2026-04-08 | 16:45 ET | [SCHEDULE 13D/A](/filings/0001193125-26-147788.md) | Ownership report, active investor, amended | 0001193125-26-147788 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000798941-26-000015.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 798941
- Tickers: FCNCA, FCNCB, FCNCN, FCNCO, FCNCP
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.